Effects of cardiac resynchronization therapy on ventricular remodeling

Current Heart Failure Reports

Volumn 5, Issue 1, 2008, Pages 25-30

  Rahmouni, Hind W ^a   Kirkpatrick, James N ^a   John Sutton, Martin G ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; CARDIOTONIC AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; HEART ATRIUM REMODELING; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE PERFORMANCE; HEART LEFT VENTRICLE REMODELING; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART RIGHT VENTRICLE REMODELING; HEART SIZE; HEART SURGERY; HEART VENTRICLE PERFORMANCE; HEART VENTRICLE REMODELING; HEART VENTRICLE VOLUME; HUMAN; MITRAL VALVE REGURGITATION; QRS COMPLEX; REVIEW; AGED; DEFIBRILLATOR; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HOSPITALIZATION; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARDIAC PACING, ARTIFICIAL; CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 47149100910     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-008-0005-1     Document Type: Review

References (38)

1. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al.: Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 2003, 289: 194-202.
2. Rosamond W, Flegal K, Friday G, et al.: Heart disease and stroke statistics - 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171. [Published erratum appears in Circulation 2007, 115:e172.]
3. Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709-717.
4. Douglas PS, Morrow R, Ioli A, Reichek N: Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989, 13:311-315.
5. Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA: Left ventricular remodeling in the year after first anterior myocardial infarction: A quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol 1992, 19:1136-1144.
6. Vasan RS, Larson MG, Benjamin EJ, et al.: Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997, 336:1350-1355.
7. White HD, Norris RM, Brown MA, et al.: Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987, 76:44-51.
8. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
9. St John Sutton MG, Plappert T, Abraham WT, et al.: Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003, 107:1985-1990.
10. He S, Fontaine AA, Schwammenthal E, et al.: Integrated mechanism for functional mitral regurgitation: Leaflet restriction versus coapting force: In vitro studies. Circulation 1997, 96:1826-1834.
11. Lancellotti P, Gerard PL, Pierard LA: Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005, 26:1528-1532.
12. St John Sutton M, Pfeffer MA, Moye L, et al.: Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 1997, 96:3294-3299.
13. Pfeffer MA, Braunwald E, Moye LA, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992, 327:669-677.
14. Konstam MA, Rousseau MF, Kronenberg MW, et al.: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 1992, 86:431-438.
15. Rahmouni H, Plappert T, St John Sutton M: Structural and functional left ventricular remodeling in heart failure with cardiac resynchronization therapy. In Cardiac Resynchronization Therapy. Edited by St John Sutton M, Bax J, Jessup M, et al.: New York: Informa Health Care; 2007:71-84.
16. Yu CM, Chau E, Sanderson JE, et al.: Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002, 105:438-445.
17. Kass DA, Chen CH, Curry C, et al.: Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999, 99:1567-1573.
18. Kanzaki H, Bazaz R, Schwartzman D, et al.: A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: Insights from mechanical activation strain mapping. J Am Coll Cardiol 2004, 44:1619-1625.
19. Sutton MG, Plappert T, Hilpisch KE, et al.: Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: Quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 2006, 113:266-272.
20. Tei C, Ling LH, Hodge DO, et al.: New index of combined systolic and diastolic myocardial performance a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995, 26:357-366.
21. Cappola TP, Harsch MR, Jessup M, et al.: Predictors of remodeling in the CRT era: Influence of mitral regurgitation, BNP, and gender. J Card Fail 2006, 12:182-188.
22. Bleeker GB, Schalij MJ, Nihoyannopoulos P, et al.: Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol 2005, 46:2264-2269.
23. Yu CM, Fang F, Zhang Q, et al.: Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure. J Am Coll Cardiol 2007, 50:778-785.
24. Abraham WT, Hayes DL: Cardiac resynchronization therapy for heart failure. Circulation 2003, 108:2596-2603.
25. Linde C, Leclercq C, Rex S, et al.: Long-term benefits of biventricular pacing in congestive heart failure: Results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 2002, 40:111-118.
26. Cleland JG, Daubert JC, Erdmann E, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539-1549.
27. Gasparini M, Bocchiardo M, Lunati M, et al.: Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: The Bi vs Left VentricAlar Pacing: an International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J 2006, 152:155.e1-155.e7.
28. Van Gelder BM, Bracke FA, Van Der Voort PH, Meijer A: Optimal sensed atrio-ventricular interval determined by paced QRS morphology. Pacing Clin Electrophysiol 2007, 30:476-481.
29. Gold MR, Niazi I, Giudici M, et al.: A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2007, 18:490-496.
30. Kedia N, Ng K, Apperson-Hansen C, et al.: Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy. Am J Cardiol 2006, 98:780-785.
31. Porciani MC, Dondina C, Macioce R, et al.: Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy. J Card Fail 2006, 12:715-719.
32. Morales MA, Startari U, Panchetti L, et al.: Atrioventricular delay optimization by doppler-derived left ventricular dP/dt improves 6-month outcome of resynchronized patients. Pacing Clin Electrophysiol 2006, 29:564-568.
33. Stockburger M, Fateh-Moghadam S, Nitardy A, et al.: Optimization of cardiac resynchronization guided by Doppler echocardiography: haemodynamic improvement and intraindividual variability with different pacing configurations and atrioventricular delays. Europace 2006, 8:881-886.
34. Gasparini M, Auricchio A, Regoli F, et al.: Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: The importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006, 48:734-743.
35. Beshai JF, Grimm RA, Nagueh SF, et al: Cardiac resynchronization in heart failure with narrow QRS complexes. N Engl J Med 2007, 357:2461-2471.
36. Ghio S, Leon A, et al.: Predictors of response to resynchronization therapy. Presented at the European Society of Cardiology Congress 2007. Vienna; September 1-5, 2007.
37. Bleeker GB, Mollema SA, Holman ER, et al.: Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: Analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation 2007, 116:1440-1448.
38. Yu CM, Bleeker GB, Fung JW, et al.: Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005, 112:1580-1586.